NCT02419898

Brief Summary

The aim of this feasibility study is to test recruitment of participants into Phase 1 of the study and then the re-recruitment and retention of participants in Phase 2 of the study. The investigators will also be assessing the acceptability of recruitment strategy and data collection to participants. The effect of pre-pregnancy factors (biophysical, genetic, socioeconomic, behavioural and psychological) on obstetric, cardiovascular, socioeconomic, behavioural and psychological outcomes will all be examined.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2013

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

January 20, 2015

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 17, 2015

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

May 11, 2018

Status Verified

May 1, 2018

Enrollment Period

5.8 years

First QC Date

January 20, 2015

Last Update Submit

May 10, 2018

Conditions

Keywords

Feasibility

Outcome Measures

Primary Outcomes (1)

  • Recruitment feasibility

    This will be measured by the number of participants recruited into Phase 1 (pre-pregnancy) and Phase 2 (pregnancy) of the study. The investigators intend to recruit 300 participants into Phase 1 and 100 participants into Phase 2.

    2 years

Secondary Outcomes (8)

  • The retention of participants in Phase 2

    2 years

  • Incidence of pregnancy within 12 months of recruitment.

    2 years in total, 12 month for each recruit

  • Live birth rate

    2 years

  • Incidence of miscarriage and ectopic pregnancy in Phase 2 participants

    2 years

  • Incidence of loss to follow-up

    2 years

  • +3 more secondary outcomes

Study Arms (1)

Feasibility Study

Nulliparous women of reproductive age (18-40 years), who are not pregnant but could have a planned or unplanned pregnancy during the duration of the study.

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Participants will be nulliparous women of reproductive age (18-40 years), who are not pregnant but could have a planned or unplanned pregnancy during the duration of the study. Participants must be willing to have research investigations before, during and after pregnancy.

You may qualify if:

  • Participant is willing and able to give informed consent for participation in the study
  • Participant is female, aged 18-40 years
  • Participant is not pregnant
  • Participant lives or works in Oxfordshire

You may not qualify if:

  • A previous live birth or still birth after 24 weeks gestation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Nuffield Department of Obstetrics and Gynaecology

Oxford, OX39DU, United Kingdom

RECRUITING

Related Publications (1)

  • Harrison S, Petkovic G, Chevassut A, Brook L, Higgins N, Kenworthy Y, Selwood M, Snelgar T, Arnold L, Boardman H, Heneghan C, Leeson P, Redman C, Granne I. Oxfordshire Women and Their Children's Health (OxWATCH): protocol for a prospective cohort feasibility study. BMJ Open. 2015 Nov 9;5(11):e009282. doi: 10.1136/bmjopen-2015-009282.

Biospecimen

Retention: SAMPLES WITH DNA

SST Serum, Citrate Platelet Free Plasma, EDTA Plasma, whole blood for DNA extraction, urine and saliva will be stored at -80°C for future studies.

MeSH Terms

Conditions

Pre-EclampsiaDiabetes, GestationalDepressionMetabolic DiseasesHypertension, Pregnancy-InducedCardiovascular Diseases

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersNutritional and Metabolic DiseasesEndocrine System DiseasesBehavioral SymptomsBehaviorHypertensionVascular Diseases

Study Officials

  • Ingrid Granne

    University of Oxford

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Research Fellow in Reproductive Medicine

Study Record Dates

First Submitted

January 20, 2015

First Posted

April 17, 2015

Study Start

April 1, 2013

Primary Completion

December 31, 2018

Study Completion

December 31, 2018

Last Updated

May 11, 2018

Record last verified: 2018-05

Locations